Annual report pursuant to Section 13 and 15(d)

Intangible assets, net (Tables)

v3.23.2
Intangible assets, net (Tables)
12 Months Ended
May 31, 2023
Intangible Assets, net  
Schedule of intangible assets

(in thousands)

    

May 31, 2023

    

May 31, 2022

Leronlimab (PRO 140) patent

$

3,500

$

3,500

Website development costs

 

20

 

20

Gross carrying value

3,520

3,520

Accumulated amortization, net of impairment

 

(3,520)

 

(3,388)

Total intangible assets, net

$

$

132